Exendin (9-39) is a shortened exendin analog focusing on the core receptor-contact region and C-terminal tail. The fragment enables detailed probing of structural determinants that modulate GLP-1 receptor engagement. Researchers compare its activity profile with longer analogs to map key residues. Its streamlined sequence is well suited for structural and binding studies.
CAT No: E10001
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More